Researcher convicted of manipulating Roche, AstraZeneca data

British regulators do not take kindly to researchers who manipulate trial data. And Steven Eaton can now attest to the extreme risks involved. He was convicted of manipulating data in animal studies for companies such as Roche ($RHHBY) and AstraZeneca ($AZN). Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.